Charles River Laboratories International Inc (NYSE:CRL)
$ 237.12 4.3 (1.85%) Market Cap: 12.21 Bil Enterprise Value: 14.73 Bil PE Ratio: 27.83 PB Ratio: 3.36 GF Score: 95/100

Charles River Laboratories International Inc at Robert W Baird Global Healthcare Conference Transcript

Sep 05, 2019 / 02:15PM GMT
Release Date Price: $133.48 (+1.34%)
Eric White Coldwell
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst

Okay. Good. Great. Good morning, everyone. My name is Eric Coldwell. I cover pharma services and health care supply chain with Baird. It's a pleasure to have Charles River with us this morning, always one of the highlights of the conference, one of the most requested companies. So Jim, thanks for being here and giving us your valued time.

For those of you who don't know Jim Foster, obviously, the CEO of the firm, been with Charles River for many years. And side note, personal note, Charles River -- I always like saying this because it makes Jim like me, Charles River is my longest-standing buy rating of all of my existing coverage, which is always fun.

For those who are new in the audience, Charles River, obviously, a company founded on research products, models used in nonclinical and preclinical research and the services that they wrap around it. About almost 20 years ago now, I guess, started to move into the nonclinical safety assessment world, what is often euphemistically

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot